Prednisone Active Not Recruiting Phase 2 Trials for Recurrent Prostate Cancer / Hormone-Resistant Prostate Cancer / Stage IV Prostate Cancer Treatment

IndicationsStatusPurposePhase
Active Not RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT01685125Abiraterone Acetate and Prednisone With or Without Dasatinib in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer